| Valley View Home Health | |
| 1520 East Hammer Lane, Suite 102, Fort Mohave, Arizona 86426 | |
| (928) 788-4140 | |
| Name | Valley View Home Health |
|---|---|
| Location | 1520 East Hammer Lane, Suite 102, Fort Mohave, Arizona |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Medical Social Services Home Health Aide |
| Medicare ID | 37412 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 86426, 86429, 86433, 86436, 86440, 86442, 86446 |
| NPI Number | 1225301096 |
| Organization Name | PHC-FORT MOHAVE INC |
| Doing Business As | VALLEY VIEW HOME HEALTH |
| Address | 1520 E Hammer Ln, Suite 102, Fort Mohave, AZ 86426 |
| Phone Number | 928-788-4140 |
News Archive
University of Alberta researchers stress that all children adopted from outside North America should be screened for tuberculosis.
Enzo Biochem, Inc., a vertically integrated biotechnology company engaged in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies, announced today a supply and distribution agreement between Enzo Life Sciences and privately-owned Cancer Genetics Inc., a leading producer of nucleic acid products used in genomic research.
In this Washington Post opinion piece, Raj Kumar, president of Devex and a member of the Council on Foreign Relations, and John Hewko, the general secretary and chief executive of Rotary International, report on the Millennium Challenge Corp. (MCC), a government "corporation" established in 2004 under the George W. Bush administration "on the premise that U.S. foreign assistance would have the greatest impact if offered on a non-political basis to developing countries that adopt sound economic and social policies."
Merck & Co., Inc. announced today that in new Phase III data, GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] was 77.5 percent (95 percent CI: 39.6, 93.3) efficacious against anal intraepithelial neoplasia (AIN) associated with human papillomavirus (HPV) types 6, 11, 16 and 18 in 16-to-26 year-old men who have sex with men. The data were presented at the European Research Organization on Genital Infection and Neoplasia (EUROGIN) conference in Monte Carlo, Monaco.
› Verified 4 days ago
| NPI Number | 1265979033 |
| Organization Name | ARIZONA IN-HOME PARTNER-II, LLC |
| Doing Business As | VALLEY VIEW HOME HEALTH |
| Address | 2020 Silver Creek Rd Ste 114, Bullhead City, AZ 86442 |
| Phone Number | 928-788-4140 |
News Archive
University of Alberta researchers stress that all children adopted from outside North America should be screened for tuberculosis.
Enzo Biochem, Inc., a vertically integrated biotechnology company engaged in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies, announced today a supply and distribution agreement between Enzo Life Sciences and privately-owned Cancer Genetics Inc., a leading producer of nucleic acid products used in genomic research.
In this Washington Post opinion piece, Raj Kumar, president of Devex and a member of the Council on Foreign Relations, and John Hewko, the general secretary and chief executive of Rotary International, report on the Millennium Challenge Corp. (MCC), a government "corporation" established in 2004 under the George W. Bush administration "on the premise that U.S. foreign assistance would have the greatest impact if offered on a non-political basis to developing countries that adopt sound economic and social policies."
Merck & Co., Inc. announced today that in new Phase III data, GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] was 77.5 percent (95 percent CI: 39.6, 93.3) efficacious against anal intraepithelial neoplasia (AIN) associated with human papillomavirus (HPV) types 6, 11, 16 and 18 in 16-to-26 year-old men who have sex with men. The data were presented at the European Research Organization on Genital Infection and Neoplasia (EUROGIN) conference in Monte Carlo, Monaco.
› Verified 4 days ago
| Quality Rating: |
News Archive
University of Alberta researchers stress that all children adopted from outside North America should be screened for tuberculosis.
Enzo Biochem, Inc., a vertically integrated biotechnology company engaged in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies, announced today a supply and distribution agreement between Enzo Life Sciences and privately-owned Cancer Genetics Inc., a leading producer of nucleic acid products used in genomic research.
In this Washington Post opinion piece, Raj Kumar, president of Devex and a member of the Council on Foreign Relations, and John Hewko, the general secretary and chief executive of Rotary International, report on the Millennium Challenge Corp. (MCC), a government "corporation" established in 2004 under the George W. Bush administration "on the premise that U.S. foreign assistance would have the greatest impact if offered on a non-political basis to developing countries that adopt sound economic and social policies."
Merck & Co., Inc. announced today that in new Phase III data, GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] was 77.5 percent (95 percent CI: 39.6, 93.3) efficacious against anal intraepithelial neoplasia (AIN) associated with human papillomavirus (HPV) types 6, 11, 16 and 18 in 16-to-26 year-old men who have sex with men. The data were presented at the European Research Organization on Genital Infection and Neoplasia (EUROGIN) conference in Monte Carlo, Monaco.
› Verified 4 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 100 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.7 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 100 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 63.8 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 69 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
University of Alberta researchers stress that all children adopted from outside North America should be screened for tuberculosis.
Enzo Biochem, Inc., a vertically integrated biotechnology company engaged in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies, announced today a supply and distribution agreement between Enzo Life Sciences and privately-owned Cancer Genetics Inc., a leading producer of nucleic acid products used in genomic research.
In this Washington Post opinion piece, Raj Kumar, president of Devex and a member of the Council on Foreign Relations, and John Hewko, the general secretary and chief executive of Rotary International, report on the Millennium Challenge Corp. (MCC), a government "corporation" established in 2004 under the George W. Bush administration "on the premise that U.S. foreign assistance would have the greatest impact if offered on a non-political basis to developing countries that adopt sound economic and social policies."
Merck & Co., Inc. announced today that in new Phase III data, GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] was 77.5 percent (95 percent CI: 39.6, 93.3) efficacious against anal intraepithelial neoplasia (AIN) associated with human papillomavirus (HPV) types 6, 11, 16 and 18 in 16-to-26 year-old men who have sex with men. The data were presented at the European Research Organization on Genital Infection and Neoplasia (EUROGIN) conference in Monte Carlo, Monaco.
› Verified 4 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 91.8 | 79.6 |
| How often patients got better at getting in and out of bed | 90.7 | 81.1 |
| How often patients got better at bathing | 95.8 | 82.3 |
| How often patients’ breathing improved | 86.7 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 91.9 | 75 |
| How often home health patients had to be admitted to the hospital | 17.9 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 19.4 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 99.4 | 94 |
News Archive
University of Alberta researchers stress that all children adopted from outside North America should be screened for tuberculosis.
Enzo Biochem, Inc., a vertically integrated biotechnology company engaged in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies, announced today a supply and distribution agreement between Enzo Life Sciences and privately-owned Cancer Genetics Inc., a leading producer of nucleic acid products used in genomic research.
In this Washington Post opinion piece, Raj Kumar, president of Devex and a member of the Council on Foreign Relations, and John Hewko, the general secretary and chief executive of Rotary International, report on the Millennium Challenge Corp. (MCC), a government "corporation" established in 2004 under the George W. Bush administration "on the premise that U.S. foreign assistance would have the greatest impact if offered on a non-political basis to developing countries that adopt sound economic and social policies."
Merck & Co., Inc. announced today that in new Phase III data, GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] was 77.5 percent (95 percent CI: 39.6, 93.3) efficacious against anal intraepithelial neoplasia (AIN) associated with human papillomavirus (HPV) types 6, 11, 16 and 18 in 16-to-26 year-old men who have sex with men. The data were presented at the European Research Organization on Genital Infection and Neoplasia (EUROGIN) conference in Monte Carlo, Monaco.
› Verified 4 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
University of Alberta researchers stress that all children adopted from outside North America should be screened for tuberculosis.
Enzo Biochem, Inc., a vertically integrated biotechnology company engaged in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies, announced today a supply and distribution agreement between Enzo Life Sciences and privately-owned Cancer Genetics Inc., a leading producer of nucleic acid products used in genomic research.
In this Washington Post opinion piece, Raj Kumar, president of Devex and a member of the Council on Foreign Relations, and John Hewko, the general secretary and chief executive of Rotary International, report on the Millennium Challenge Corp. (MCC), a government "corporation" established in 2004 under the George W. Bush administration "on the premise that U.S. foreign assistance would have the greatest impact if offered on a non-political basis to developing countries that adopt sound economic and social policies."
Merck & Co., Inc. announced today that in new Phase III data, GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] was 77.5 percent (95 percent CI: 39.6, 93.3) efficacious against anal intraepithelial neoplasia (AIN) associated with human papillomavirus (HPV) types 6, 11, 16 and 18 in 16-to-26 year-old men who have sex with men. The data were presented at the European Research Organization on Genital Infection and Neoplasia (EUROGIN) conference in Monte Carlo, Monaco.
› Verified 4 days ago
The patient survey data of Valley View Home Health is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 90 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 92 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 92 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 84 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 78 | 78 |
News Archive
University of Alberta researchers stress that all children adopted from outside North America should be screened for tuberculosis.
Enzo Biochem, Inc., a vertically integrated biotechnology company engaged in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies, announced today a supply and distribution agreement between Enzo Life Sciences and privately-owned Cancer Genetics Inc., a leading producer of nucleic acid products used in genomic research.
In this Washington Post opinion piece, Raj Kumar, president of Devex and a member of the Council on Foreign Relations, and John Hewko, the general secretary and chief executive of Rotary International, report on the Millennium Challenge Corp. (MCC), a government "corporation" established in 2004 under the George W. Bush administration "on the premise that U.S. foreign assistance would have the greatest impact if offered on a non-political basis to developing countries that adopt sound economic and social policies."
Merck & Co., Inc. announced today that in new Phase III data, GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] was 77.5 percent (95 percent CI: 39.6, 93.3) efficacious against anal intraepithelial neoplasia (AIN) associated with human papillomavirus (HPV) types 6, 11, 16 and 18 in 16-to-26 year-old men who have sex with men. The data were presented at the European Research Organization on Genital Infection and Neoplasia (EUROGIN) conference in Monte Carlo, Monaco.
› Verified 4 days ago
Valley View Home Health Location: 1520 East Hammer Lane, Suite 102, Fort Mohave, Arizona 86426 Ratings: Phone: (928) 788-4140 |